New Index Ranking 11 Countries’ Ability to Tackle Rising Threat of Resistance to Antimicrobials Shows Need for Urgent Action

The 2021 AMR Preparedness Index assesses how well national governments are fulfilling their high-level commitments to address the accelerating crisis in antimicrobial resistance

New York, NEW YORK and Washington, DC (June 23, 2021) – Today the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the first-ever global AMR Preparedness Index, a first-of-its-kind evaluation of how the governments of the 11 largest global economies are living up to their commitments to address antimicrobial resistance (AMR). Released amid increasing recognition of the threat posed by the “silent pandemic” of antimicrobial resistance at the highest levels of government, most recently at the G7 Summit in Cornwall, the report identifies a broad failure to match public promises with the concrete actions needed to avert the growing crisis. The index assessed the 11 largest global economiesBrazil, Canada, China, France, Germany, India, Italy, Japan, South Korea, the United Kingdom (UK), and the United States (US). The report also offers case studies from Australia, Kenya, Russia, Saudi Arabia, and Sweden. The UK and US topped the Index list.

“Increasing resistance to life-saving antimicrobials, together with our broken innovation pipeline, threatens to erode the very foundation of modern medicine and, with it, erase one of the principal achievements of the 20th century – the miracle of human longevity,” said Michael Hodin, CEO of the Global Coalition on Aging. “As the United Nations (UN) and World Health Organization (WHO) Decade of Healthy Ageing brings greater attention and energy to our remarkable demographic achievement and the COVID-19 experience make clear the compounded risk to older adults from infectious disease, we must fully acknowledge the threat that AMR poses to the very prospect of healthy and active aging. Without true action to effectively address AMR, tens of millions of lives – both young and old – will be cut short, and so many others will be diminished as a result of care foregone over concerns about now untreatable infection,” said Hodin.

The 2021 AMR Preparedness Index is a tool to support evidence-based decision making and help avert this urgent public health crisis. It assesses countries across seven categories identified by experts as critical to successfully addressing AMR, highlighting best practices, identifying priority areas for government action, and offering a framework for countries and stakeholders to hold themselves accountable and benchmark progress on AMR.

An estimated 700,000 people die each year from drug-resistant infections and the lack of novel antimicrobials to treat them. With rising resistance to our existing drugs, routine medical care – ranging from outpatient chemotherapy for cancer, to a knee replacement to even a root canal – increasingly places us at risk of a debilitating or life-threatening infection.  If unaddressed, the continued rise of AMR is expected to lead to as many as 10 million deaths per year, disability and lower quality of life for millions more, and $100 trillion in lost GDP by 2050.

“The COVID-19 pandemic has made painfully clear to all the far-reaching impact of untreatable infectious diseases across societies and economies,” said IDSA President Dr. Barbara Alexander. “As we enter the next stage of the pandemic and with global momentum for AMR action building among G7 countries – in the UK with the launch of the subscription pilot, and most recently, with the reintroduction of the PASTEUR Act in the US Congress – the 2021 AMR Preparedness Indexcomes at a pivotal moment. We are pleased to partner with the Global Coalition on Aging to create this vital tool that will help governments around the world reinforce their words with actions,” said Dr. Alexander.

The 2021 AMR Preparedness Index assigns scores to each of the 11 countries across seven categories as guidance for needed and achievable policy action. The analysis includes key findings and highlights critical actions that governments should immediately prioritize to fulfill their commitments on AMR. Drug resistance is borderless, and all countries must lead with concerted action within their borders to slow the growth of resistance in their hospitals and waterways, and to foster the ability for innovations to reach patients in need. Of those evaluated in the Index, the UK and the US can be seen as examples, scoring highest in the evaluation.

Critical opportunities for government action identified in the Index include to:

  • Strengthen and fully implement national AMR strategies
  • Raise awareness of AMR and its consequences, while targeting prevention opportunities
  • Bolster surveillance and leverage data across AMR efforts
  • Enable a restructured antimicrobial marketplace to stimulate innovation
  • Promote responsible and appropriate use of antibiotics
  • Enable reliable and consistent access to needed and novel antimicrobials
  • More effectively integrate the One Health approach, including environmental considerations arising from human, veterinary, and agricultural use of antibiotics, into national strategies
  • Better engage with other governments, third-party organizations, and advocacy groups

The insights provided by the 2021 AMR Preparedness Index were the result of over one thousand hours of data collection and evaluation of existing research gathered from global authorities, including the Center for Disease Dynamics, Economics and Policy (CDDEP); the Global AMR R&D Hub; and the WHO, as well as reports from national governments, nonprofits, and academia. The findings were then supplemented and validated by interviews and surveys with global key opinion leaders and subject matter experts (including scientists, advocates, researchers, clinicians, business leaders, and policymakers). The Index was also reviewed by a preeminent and global third-party Advisory Council and experts from the Infectious Diseases Society of America.

Featured during today’s launch of the Index are:

  • Anand Anandkumar, Founder and CEO, Bugworks Research, India
  • James Anderson, Executive Director, Global Health, IFPMA
  • Christine Årdal, Co-Lead, Research and Innovation, EU-JAMRAI
  • Neil J. Clancy, Chief, Infectious Diseases, VA Pittsburgh Health Care System; Associate Professor of Medicine, University of Pittsburgh School of Medicine; and AMR Committee, Infectious Diseases Society of America
  • Michael W. Hodin, CEO, Global Coalition on Aging
  • Norio Ohmagari, Director, Department of Infectious Diseases, National Center for Global Health and Medicine Hospital, Japan
  • Susan Wile Schwarz, Director of Communications, Global Coalition on Aging
  • Tiemo Wölken, Member of European Parliament, Germany

The development of the 2021 AMR Preparedness Index was sponsored by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).

About the Infectious Diseases Society of America:

IDSA is a leader on issues of importance to ID professionals, including education and training, policy and advocacy, setting guidelines for patient care, and developing resources for clinical practice. It remains at the forefront of global health issues such as COVID-19, antimicrobial resistance and HIV/AIDS. Housed within IDSA is the HIV Medicine Association, (HIVMA) which represents medical providers and researchers working on the front lines of HIV. More than 12,000 IDSA and HIVMA members work across the United States and in nearly 100 other countries on six different continents.  For more information visit www.idsociety.org. Follow IDSA on  Facebook and Twitter.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.